Friday, August 17, 2018
Tags Luxturna

Tag: Luxturna

Lonza’s Virus Factory Shows Gene Therapy’s Texas-Sized Promise

By John Miller ZURICH (Reuters) Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative...

Drugmakers See a Pricing Blueprint in An $850,000 Gene Therapy

By Caroline Humer SAN FRANCISCO (Reuters) Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for...

Spark’s Price for Luxturna Blindness Gene Therapy Too High: ICER

By Bill Berkrot (Reuters) The proposed price for Spark Therapeutics Inc's <ONCE.O> groundbreaking one-time gene therapy for a rare form of blindness is far too high,...
banner